Bionomics Analyst Ratings
Bionomics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 12/20/2022 | 1.87% | Evercore ISI Group | $17 → $6 | Downgrades | Outperform → In-Line |
| 12/19/2022 | — | HC Wainwright & Co. | Downgrades | Buy → Neutral | |
| 11/01/2022 | 290.49% | Loop Capital | → $23 | Initiates Coverage On | → Buy |
| 01/10/2022 | 782.85% | Cantor Fitzgerald | → $52 | Initiates Coverage On | → Overweight |
| 01/10/2022 | 188.62% | Evercore ISI Group | → $17 | Initiates Coverage On | → Outperform |
| 01/10/2022 | 256.54% | Berenberg | → $21 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 12/20/2022 | 1.87% | Evercore ISI集团 | $17 → $6 | 评级下调 | 胜过→同线 |
| 12/19/2022 | — | HC Wainwright公司 | 评级下调 | 购买→中性 | |
| 11/01/2022 | 290.49% | 环路资本 | → $23 | 开始承保 | →购买 |
| 01/10/2022 | 782.85% | 康托·菲茨杰拉德 | → $52 | 开始承保 | →超重 |
| 01/10/2022 | 188.62% | Evercore ISI集团 | → $17 | 开始承保 | →跑赢大盘 |
| 01/10/2022 | 256.54% | 贝伦伯格 | → $21 | 开始承保 | →购买 |
What is the target price for Bionomics (BNOX)?
生物制药(BNOX)的目标价是多少？
The latest price target for Bionomics (NASDAQ: BNOX) was reported by Evercore ISI Group on December 20, 2022. The analyst firm set a price target for $6.00 expecting BNOX to rise to within 12 months (a possible 1.87% upside). 6 analyst firms have reported ratings in the last year.
生物制药(纳斯达克代码：BNOX)的最新目标价是由Evercore ISI Group于2022年12月20日报告的。这家分析公司将目标价定为6.00美元，预计BNOX将在12个月内升至(可能上涨1.87%)。6家分析公司在过去一年公布了评级。
What is the most recent analyst rating for Bionomics (BNOX)?
生物学(BNOX)的最新分析师评级是多少？
The latest analyst rating for Bionomics (NASDAQ: BNOX) was provided by Evercore ISI Group, and Bionomics downgraded their in-line rating.
对生物科技(纳斯达克代码：BNOX)的最新分析师评级由Evercore ISI Group提供，生物科技下调了其在线评级。
When is the next analyst rating going to be posted or updated for Bionomics (BNOX)?
生物学(BNOX)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bionomics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bionomics was filed on December 20, 2022 so you should expect the next rating to be made available sometime around December 20, 2023.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Bionomics的高管和客户交谈，以及收听收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。生物学的上一次评级是在2022年12月20日提交的，所以你应该预计下一次评级将在2023年12月20日左右的某个时候公布。
Is the Analyst Rating Bionomics (BNOX) correct?
分析师评级生物学(BNOX)正确吗？
While ratings are subjective and will change, the latest Bionomics (BNOX) rating was a downgraded with a price target of $17.00 to $6.00. The current price Bionomics (BNOX) is trading at is $5.89, which is out of the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的生物科技(BNOX)评级被下调，目标价为17.00美元至6.00美元。生物科技(BNOX)目前的交易价格为5.89美元，超出了分析师的预测范围。